Literature DB >> 11463935

Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica.

M Smikle1, G Dowe, T Hylton-Kong, E Williams.   

Abstract

OBJECTIVES: To determine the prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV) infections, and risk factors for HCV and HBV infections in sexually transmitted disease (STD) clinics in Jamaica.
METHODS: A prospective observational cohort study was carried out. Blood was collected from 485 consecutive patients attending the comprehensive health centre in Kingston, Jamaica. Serum was tested using commercially prepared reagents and standard procedures for antibodies to HCV (anti-HCV), hepatitis B core antigen (anti-HBc), hepatitis B surface antigen (HBsAg), HIV-1 infection, and syphilitic infection. Sociodemographic and sexual characteristics of the patients were recorded for assessment as risk factors for HCV and HBV infections.
RESULTS: None of the patients had anti-HCV, 21.0% had anti-HBc, 3.2% HBsAg, 2.5% tested positive for HIV-1, and 5.2% had reactive serological test for syphilis. Age was the only independent risk factor identified for anti-HBc positivity.
CONCLUSIONS: The data obtained in this study were not in support of sexual transmission of HCV or HBV infections in Jamaica. Carefully designed multicentre studies could provide more consistent information on the transmission of these viruses by sexual routes.

Entities:  

Mesh:

Year:  2001        PMID: 11463935      PMCID: PMC1744331          DOI: 10.1136/sti.77.4.295

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  4 in total

1.  Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.

Authors:  S D King; R Y Dodd; G Haynes; H H Wynter; M T Sullivan; G R Serjeant; E Choo-Kang; E Michael
Journal:  West Indian Med J       Date:  1995-06       Impact factor: 0.171

2.  Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Authors:  O E Santana Rodríguez; M L Malé Gil; J F HernándezSantana; J M Limiñana Cañal; A M Martín Sánchez
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

3.  Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.

Authors:  D L Thomas; R O Cannon; C N Shapiro; E W Hook; M J Alter; T C Quinn
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

4.  Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases.

Authors:  H S Weinstock; G Bolan; A L Reingold; L B Polish
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

  4 in total
  8 in total

Review 1.  Hepatitis B virus infection in Latin America: a genomic medicine approach.

Authors:  Sonia Roman; Alexis Jose-Abrego; Nora Alma Fierro; Griselda Escobedo-Melendez; Claudia Ojeda-Granados; Erika Martinez-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

2.  Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Authors:  Toni Frederick; Pamela Burian; Norah Terrault; Mardge Cohen; Michael Augenbraun; Mary Young; Eric Seaberg; Jessica Justman; Alexandra M Levine; Wendy J Mack; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

3.  Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4.

Authors:  Jenny Martial; Yoann Morice; Sylvie Abel; André Cabié; Christelle Rat; Frédéric Lombard; André Edouard; Serge Pierre-Louis; Philippe Garsaud; Odile Béra; Roger Chout; Emmanuel Gordien; Paul Deny; Raymond Césaire
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 4.  Sexually acquired hepatitis.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

Review 5.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

6.  Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti.

Authors:  Matthew J Hepburn; Eric J Lawitz
Journal:  BMC Gastroenterol       Date:  2004-12-14       Impact factor: 3.067

7.  Prevalence and determinants of hepatitis B antigenemia in 15,007 inmates in Taiwan.

Authors:  Ching-Feng Lin; Shiing-Jer Twu; Ping-Ho Chen; Jror-Serk Cheng; Jung-Der Wang
Journal:  J Epidemiol       Date:  2010-04-20       Impact factor: 3.211

8.  Sexual activity and hepatitis B and C virus infection among young adults after introduction of a vaccination program in an area of high endemicity.

Authors:  Min Kyung Lim; Silvia Franceschi; Salvatore Vaccarella; Young-Hee Ju; Jin-Kyoung Oh; Hyun-Joo Kong; Dong-Il Kim; Byoung-Gwon Kim; Jung-Il Kim; Kap-Yeol Jung; Dong-Soon Lee; Hai-Rim Shin
Journal:  J Epidemiol       Date:  2009-08-01       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.